- Home
- PERF vs NYXH Comparison
PERF vs NYXH Comparison
Compare PERF & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PERF
- NYXH
- Stock Information
- Founded
- PERF 2015
- NYXH 2009
- Country
- PERF Taiwan
- NYXH Belgium
- Employees
- PERF N/A
- NYXH 184
- Industry
- PERF Computer Software: Prepackaged Software
- NYXH Medical/Dental Instruments
- Sector
- PERF Technology
- NYXH Health Care
- Exchange
- PERF Nasdaq
- NYXH Nasdaq
- Market Cap
- PERF 191.5M
- NYXH 196.7M
- IPO Year
- PERF N/A
- NYXH 2021
- Fundamental
- Price
- PERF $2.07
- NYXH $5.24
- Analyst Decision
- PERF Buy
- NYXH Strong Buy
- Analyst Count
- PERF 1
- NYXH 3
- Target Price
- PERF $5.00
- NYXH $15.00
- AVG Volume (30 Days)
- PERF 147.3K
- NYXH 83.6K
- Earning Date
- PERF 10-28-2025
- NYXH 11-05-2025
- Dividend Yield
- PERF N/A
- NYXH N/A
- EPS Growth
- PERF 4.30
- NYXH N/A
- EPS
- PERF 0.06
- NYXH N/A
- Revenue
- PERF $64,369,000.00
- NYXH $5,793,306.00
- Revenue This Year
- PERF $15.84
- NYXH $118.20
- Revenue Next Year
- PERF $14.54
- NYXH $278.04
- P/E Ratio
- PERF $34.65
- NYXH N/A
- Revenue Growth
- PERF 13.19
- NYXH 2.94
- 52 Week Low
- PERF $1.51
- NYXH $5.24
- 52 Week High
- PERF $3.44
- NYXH $11.87
- Technical
- Relative Strength Index (RSI)
- PERF 55.18
- NYXH 27.77
- Support Level
- PERF $1.88
- NYXH $5.45
- Resistance Level
- PERF $1.97
- NYXH $6.09
- Average True Range (ATR)
- PERF 0.09
- NYXH 0.26
- MACD
- PERF 0.01
- NYXH -0.04
- Stochastic Oscillator
- PERF 70.32
- NYXH 0.00
About PERF Perfect Corp.
Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.